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AbstrACt
Objectives To determine whether stroke patients’ acute 
hospital length of stay (AHLOS) varies between hospitals, over 
and above case mix differences and to investigate the hospital-
level explanatory factors.
Design A multicentre prospective cohort study.
setting Eight National Health Service acute hospital trusts 
within the Anglia Stroke & Heart Clinical Network in the East of 
England, UK.
Participants The study sample was systematically selected to 
include all consecutive patients admitted within a month to any 
of the eight hospitals, diagnosed with stroke by an accredited 
stroke physician every third month between October 2009 and 
September 2011.
Primary and secondary outcome measures AHLOS was 
defined as the number of days between date of hospital 
admission and discharge or death, whichever came first. We 
used a multiple linear regression model to investigate the 
association between hospital (as a fixed-effect) and AHLOS, 
adjusting for several important patient covariates, such as 
age, sex, stroke type, modified Rankin Scale score (mRS), 
comorbidities and inpatient complications. Exploratory data 
analysis was used to examine the hospital-level characteristics 
which may contribute to variance between hospitals. These 
included hospital type, stroke monthly case volume, service 
provisions (ie, onsite rehabilitation) and staffing levels.
results A total of 2233 stroke admissions (52% female, 
median age (IQR) 79 (70 to 86) years, 83% ischaemic stroke) 
were included. The overall median AHLOS (IQR) was 9 (4 to 
21) days. After adjusting for patient covariates, AHLOS still 
differed significantly between hospitals (p<0.001). Furthermore, 
hospitals with the longest adjusted AHLOS’s had predominantly 
smaller stroke volumes.
Conclusions We have clearly demonstrated that AHLOS 
varies between different hospitals, and that the most important 
patient-level explanatory variables are discharge mRS, 
dementia and inpatient complications. We highlight the potential 
importance of stroke volume in influencing these differences 
but cannot discount the potential effect of unmeasured 
confounders.
IntrODuCtIOn  
Stroke is the second leading cause of mortality 
and the third leading cause of disability in the 
world, with a global incidence of 16.9 million 
in 2010.1 2 While acute hospitalisation for 
stroke in the US has been estimated at a cost of 
$31 667 per patient, total direct stroke-related 
annual medical costs are expected to triple, 
from $71.6 billion in 2012 to $184.1 billion by 
2030.3 4 
Considerable differences in stroke-related 
outcomes exist worldwide, with the highest 
age-standardised stroke-related mortality and 
disability adjusted life-years rates observed in 
Russia and Eastern European countries.1 Stark 
regional disparities within countries are also 
apparent. In the UK, for example, there exists 
strengths and limitations of this study
 ► This is a comprehensive study that has used mul-
ticentre data to determine whether acute hospital 
length of stay of patients with stroke varies across 
hospitals in the UK, after adjustment for patient-lev-
el covariates, such as age, sex, prestroke and dis-
charge modified Rankin Scale score, stroke type, 
residence prior to stroke, comorbidities and inpa-
tient complications.
 ► With a wealth of detailed patient data, we were 
able to adjust for the important covariates, inpatient 
complications and discharge modified Rankin Scale 
score, which previous studies have not addressed 
when investigating hospital-level factors.
 ► Although hospital-level effect estimates were not 
calculated due to the limited hospital sample size 
of eight, we explored these factors descriptively and 
adjusted for clustering by including hospital as a 
fixed-effect.
 ► Although National Institute for Health Stroke Scale, 
which is used to measure the severity of stroke, is 
known to be associated with acute hospital length 
of stay, we were unable to take this variable into 
account since it was only calculated on admission 
for patients who were potentially eligible for throm-
bolysis, and would have introduced information bias.  on
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a clear north–south divide where the lowest stroke-related 
mortality rates are observed almost exclusively in the 
South of England.5 Such differences in outcomes likely 
reflect underlying stroke incidence rates and variations 
in exposure to relevant risk factors.5 6 However, we and 
others have demonstrated that some of the differences 
in poststroke survival have also been explained by dispar-
ities in available resources and medical care.7–11 Studies 
assessing the effect of stroke care heterogeneities have 
largely focused on mortality as the primary outcome.
However, it is possible that heterogeneities in stroke 
care also impact other important stroke-related outcomes, 
such as a patient’s acute hospital length of stay (AHLOS). 
To date, researchers have mainly identified patient-re-
lated determinants of AHLOS,12–15 with little explora-
tion into hospital-level influences. Of the few studies that 
have investigated hospital-level variance, factors such 
as hospital type, size, teaching status and location have 
been implicated in partially explaining differences in 
AHLOS.12 16–19 None such studies have been conducted 
in a UK National Health Service (NHS) setting.
During acute hospitalisation, AHLOS is the main driver 
of acute care costs.20 Determining the hospital-level 
factors influencing AHLOS therefore provides invaluable 
information to service providers and policymakers who 
can develop optimal management strategies and enhance 
patient care by minimising service deficiencies, costs and 
bed shortages.
The aim of this study was to investigate whether there 
are variations in stroke patients’ AHLOS which can be 
partly explained by heterogeneities in characteristics of 
stroke care between hospitals in a UK NHS setting. We 
also aimed to explore which hospital-level factors explain 
such hospital variations in AHLOS.
MethODs
study design
A multicentre prospective cohort study was conducted 
at eight acute NHS Trusts within the Anglia Stroke & 
Heart Clinical Network (ASHCN) which covers the three 
counties of Suffolk, Norfolk and Cambridgeshire, in the 
East of England with a catchment population of approxi-
mately 2.5 million. The detailed study protocol has previ-
ously been published (see online supplementary file 1).21
Participants
The study population included all patients, aged 18 years 
or older, admitted to any of the eight hospitals within the 
ASHCN diagnosed with stroke by an accredited stroke 
physician between October 2009 and September 2011. 
Stroke was defined as a focal neurological impairment of 
sudden onset and lasting more than 24 hours (or leading 
to death) as a consequence of an intracerebral ischaemic 
or haemorrhagic event. This definition excludes diag-
noses of transient-ischaemic attacks (TIAs), subdural 
haematomas and subarachnoid haemorrhages. Stroke 
diagnosis was confirmed in all patients with stroke through 
cerebral imaging (either using CT or MRI). Diagnoses by 
the stroke physician were coded using International Clas-
sification of Diseases-10. The study sample was system-
atically selected to include all consecutive patients with 
stroke admitted every third month of this 2-year period, 
resulting in a total of eight study months and a sample 
size of 2656. The robustness of this sampling technique 
has been confirmed.22
Participant hospitals
The participating hospitals, although part of the same 
network, do not coordinate the care of patients or work 
together to provide regional care. They are independent 
NHS Trusts that serve their local communities and there-
fore are individually responsible for managing patients 
with stroke. Admission, transfer and discharge policies 
should be similar across these hospitals. There are also 
no known differences in access to rehabilitation, home 
care or nursing homes.
Stroke services available at each site should be propor-
tionate to the hospital’s catchment population. However, 
as stroke volumes differ, some hospitals may experience 
greater pressure on their resources and facilities than 
others. Access to available resources also varies between 
the hospitals, with some providing onsite rehabilita-
tion, neurosurgery and vascular surgery. Palliative care 
management may also differ between the sites.
Data collection
Clinical teams responsible for the care of patients with 
stroke in each of the hospitals prospectively recorded 
individual patient data. Patient data routinely collected 
by each participating site for the ASHCN surveys was used 
in this study. Additional baseline patient and outcome 
data were also retrieved from case records, discharge 
summaries and patient administrative systems by the clin-
ical teams. Data were anonymised and sent to the ASHCN 
coordinating centre where it was collated and sent to the 
research team. Any identifiable patient information was 
held only at the local NHS Trusts—the network and inves-
tigators did not have access to these details.
Data on health service characteristics were collected 
from clinical leads or service managers at each stroke unit 
and updated every 6 months over the 2-year study period 
by research staff.21 No major changes in health service 
characteristics occurred during the study data collection 
period. Some changes that did occur included: minor 
fluctuations in staffing levels, number of non-stroke 
patients treated on the stroke unit and number of patients 
with stroke treated outside the stroke unit. In the final 
year of study, hospital 5 introduced a further CT scanner, 
increasing their total to three. Furthermore, for hospitals 
5 and 6 some reconfigurations from acute stroke unit beds 
to hyperacute stroke unit beds were made. Hospital 4 also 
introduced hyperacute stroke unit beds in the final year 
of study and increased the number of acute stroke unit 
beds available. We have accounted for these fluctuations 
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by calculating and reporting the weighted average across 
the four study periods for these measures.
Definition of variables
Our outcome measure, AHLOS, was treated as a contin-
uous variable and defined as the number of days from, 
and including, the patients’ date of hospital admission to 
their date of discharge or death, whichever came first.
Patient-level covariates adjusted for were: age (treated 
as a continuous variable), sex, prestroke modified Rankin 
Scale (mRS) as an indicator of prestroke frailty, prestroke 
residence status, stroke type, Oxfordshire Community 
Stroke Project (OCSP) (a stroke classification system), 
presence or absence of lateralisation signs, acute inpa-
tient complications (such as another stroke, pneumonia, 
urinary tract infection (UTI), seizures, myocardial infarc-
tion, acute coronary syndrome), established comorbidi-
ties (including previous stroke/TIA, previous myocardial 
infarction or ischaemic heart disease, previous cancer), 
presence of other relevant comorbidities (including 
diabetes mellitus, dementia, hypercholesterolaemia, 
hypertension, cancer, depression, rheumatoid arthritis 
and chronic obstructive pulmonary disease), day and 
season of admission and discharge mRS (including 
in-hospital death). An inpatient complication was defined 
as any disease, disorder or condition that developed after 
the index stroke that is, during the acute admission, 
whereas comorbidities were defined as those that were 
known to have occurred prior to stroke.
Independent hospital-level variables of interest were: 
hospital type (secondary or tertiary), hospital stroke 
volume (mean number of patients with stroke admitted 
and treated in hospital per month), presence of vascular 
surgery onsite, distance to neurosurgical facility, onsite 
rehabilitation service provision, presence of an early 
supported discharge scheme, number of full-time equiv-
alent (fte) staff per five beds (senior doctors and junior 
doctors available during weekdays, healthcare associates 
and nurses, occupational therapists, physiotherapists and 
speech and language therapists), number of total beds 
present on the stroke unit per 100 stroke admissions, 
total number of hospital beds per CT scanner, number 
of non-stroke patients treated daily on the stroke unit per 
five beds, number of patients with stroke treated daily on 
wards outside the stroke unit per day per five beds and 
the mean index of multiple deprivation (IMD) of the 
county in which each hospital serves.
In NHS England, hospitals are either termed secondary 
or tertiary, depending on the level of specialist service 
provided. Tertiary hospitals provide more specialised 
care in larger, regional or national centres compared 
with their secondary counterparts for example, neurosur-
gery unit where smaller units are not viable nor practical. 
These more centralised hospitals are usually dedicated in 
providing superspecialty care beyond sub-specialty (eg, 
neuro-endocrine surgery is a superspecialty of neurosur-
gery which is a subspecialty of the specialty of surgery), 
and therefore have access to more advanced equipment 
and expertise specific to the conditions in which it subspe-
cialises. This does not apply to stroke directly, but it is 
relevant for those who have stroke and require neurosur-
gical intervention.
Five bed days was used as the denominator as this is how 
the 2016 national clinical guidelines for stroke reports 
the recommended staffing levels for UK stroke units, and 
therefore provides for a comparison.23
The IMD score was used as an aggregate measure of 
socioeconomic status in this study. This measure is based 
on several domains, including income, employment, 
education, health, crime, barriers to housing and services 
and the living environment, that are believed to provide 
an indication of deprivation. To assign an IMD score, 
England is subdivided into 32 844 smaller areas, with a 
score of 1 representing the area in England that is consid-
ered to be the most deprived and a score of 32 844 the 
least deprived.24 In our study, we have taken the mean 
2010 IMD scores of the areas that make up the counties of 
Suffolk, Norfolk and Cambridgeshire and assigned these 
to each of the hospitals to which they are located.25
We believe processes of care measures are intermediate 
variables that lie on the casual pathway between hospi-
tal-level factors and patient outcomes of stroke.10 As such, 
we did not adjust for these covariates in the analyses. 
Including them in our regression model could otherwise 
lead to over-adjustment bias.26 27
statistical analyses
Data were available from only eight hospitals which is 
below the suggested critical number required to reliably 
estimate hospital effects through multilevel modelling.28 
Therefore, a single-level multiple linear regression model 
using ordinary least squares was conducted with hospital 
as a fixed-effect and AHLOS as the outcome. To qualify 
for inclusion in the multivariable model, patient-level 
variables had to have a p value <0.3 in univariable analysis. 
The standardised residuals of the model were positively 
skewed. However, a logarithmic transformation of AHLOS 
subsequently removed the skewness. Before reporting, we 
transformed the predicted logarithmic AHLOS values 
back to AHLOS, with exponentiated regression coeffi-
cients representing geometric means of AHLOS.
To explore hospital-level factors, we plotted the hospital 
intercept estimates of AHLOS from the regression model 
(mean baseline AHLOS of each hospital), against the 
hospital-level characteristics of interest. This is the recom-
mended method to use on clustered data to explore 
hospital effects when the number of higher level units is 
small and hence are not interpretable in likelihood esti-
mation.28 29
sensitivity analyses
Due to limited resources, hospital 2 failed to collect data 
for the full study period. Patient-level data were only 
collected in this hospital for October 2009 and January 
2010, culminating in a small number of stroke cases for 
analysis (n=16). To investigate whether this small cluster 
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may affect our results, we performed a sensitivity analysis 
excluding hospital 2.
Furthermore, although we collected patient data on 
discharge destination, we did not include this as a covariate 
in our multiple regression model due to issues of multi-
collinearity with discharge mRS (both had categories for 
inpatient death). We hypothesised that discharge mRS 
could more readily explain a patient’s AHLOS indirectly 
through discharge destination (ie, more severe disability 
increases the risk of institutionalisation which prolongs 
AHLOS due to associated waiting lists) and directly 
through patient recovery (ie, a patient with more severe 
disability will likely take longer to recover than a patient 
with no disability, meaning it will take longer for a safe 
patient discharge). If we were to include discharge desti-
nation instead, AHLOS variance due to differences in 
disability and recovery time among patients with the same 
discharge placement would not be taken into account. To 
check the impact of excluding discharge destination on 
our findings, we have performed a further sensitivity anal-
ysis replacing discharge mRS with discharge destination 
in our multiple regression model.
Multiple imputation
To increase power and reduce potential bias of complete 
case analysis, we performed multiple imputation by 
chained equations using the MICE package in R.30 All the 
independent variables of interest, AHLOS and a number 
of auxiliary variables (ie, variables in our dataset that were 
not used in our model) (see table S1 in the online supple-
mentary file 2) informed the imputation. Sixty-four data-
sets were imputed as the inclusion of auxiliary variables 
increased the casewise missingness to 64%. Each dataset 
was pooled together using Rubin’s rules.31 The distribu-
tion of sample characteristics between individuals with 
complete and incomplete data were compared using the 
appropriate hypothesis testing. Complete case analysis 
was also conducted so that any differences in results from 
the multiple imputation analysis could be reported.
All analyses were performed using R V.3.3.1 for 
Windows.32
Patient and public involvement
The project was managed by project leader (PKM) who 
worked in close partnership with the project group of 
the study and the project steering group. The project 
steering group included public and patient representa-
tives, recruited through patient and public involvement 
in research (PPIRes). PPIRes members were invited to 
attend research steering group meetings over the study 
duration to oversee the project.
results
Description of sample characteristics
Of the 2656 patients admitted consecutively to the eight 
NHS hospitals during the inclusion period with an initial 
diagnosis of stroke, 278 were excluded for the following 
reasons: eventually diagnosed with a condition other 
than stroke (n=179), transferred between hospitals (both 
among the eight study hospitals and from or to outside 
the region) (n=101), had missing data for admission and 
discharge dates (n=8). This left a total of 2233 patients for 
the study analysis (figure 1).
The median age (IQR) of our cohort was 79 (70 to 86) 
years, 52% were female and 83% had an ischaemic stroke 
(table 1). The distributions of patient characteristics 
appeared to vary between hospitals (see table S2 in the 
online supplementary file 2). Although there were low 
proportions of missing data for each independent vari-
able (table 1), this compounded to 33% of patients having 
at least one variable missing. Hospital 4 did not collect 
data on prestroke mRS and 30 cases from hospital 3 had 
missing data on all comorbidities. Patients with complete 
data were less likely to have a haemorrhagic stroke, be 
institutionalised prior to stroke and have an inpatient 
death, and more likely to have had a previous stroke or 
TIA, have hypercholesterolaemia, hypertension, rheuma-
toid arthritis, have a lacunar stroke and have a discharge 
mRS of 6, than patients who had at least one missing vari-
able. However, there were no significant differences in 
other patient characteristics such as age, sex, prestroke 
mRS score, brain lateralisation, inpatient complication 
and admission timing between the two groups (see table 
S3 in the online supplementary file 2).
hospital service characteristics
Service characteristics of each hospital are outlined in 
table 2, with median AHLOS.
After standardisation, by taking account of stroke 
admission volume, number of stroke unit beds and size 
of hospital, there was still extensive heterogeneity in bed 
capacity, staffing levels and the number of CT scanners 
provided at each hospital, respectively. Variations between 
hospitals also existed in terms of service and facility provi-
sion. For example, a number of hospitals provided reha-
bilitation care, neurosurgery or vascular surgery onsite, 
while others did not. The overall median AHLOS (IQR) 
was 9 (4 to 21) days and there appeared to be crude vari-
ations in this outcome between hospitals.
univariable linear regression
In univariable linear regression (see table S4 in the online 
supplementary file 2), patients who were older, female, had 
previous cancer, a previous stroke, had diabetes mellitus, 
had dementia, had a prestroke or discharge mRS score 
greater than 0, had a OCSP other than a lacunar infarct, 
had an inpatient complication, were living independently 
at home without formal care (compared with those who 
had formal care) prior to stroke, or were a winter admis-
sion had a significantly longer AHLOS (p<0.05). Patients 
who had a haemorrhagic stroke, hypercholesterolaemia, 
or showed no signs of brain lateralisation were all shown 
to be significantly associated with a shorter AHLOS 
(p<0.01).
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The strongest associations with AHLOS were seen for 
inpatients who developed a complication, who had a 
prestroke mRS score of 3, who were admitted to hospital 2 
or who had a discharge mRS score of ≥2. Inpatient compli-
cations were associated with twice as long an AHLOS 
compared with those without a complication. Similarly, 
patients with a prestroke mRS score of 3 were 94% more 
likely to have a longer AHLOS than those with an mRS 
of 0. Patients admitted to hospital 2 had 2.69 times the 
AHLOS of those admitted to hospital 1. Compared with 
patients with a discharge mRS score, those with a score 
of 2, 3, 4 or 5 had over a 2, 3, 4 and 5-fold increase in 
AHLOS, respectively. Unsurprisingly, discharge mRS 
score appeared to explain the majority of AHLOS vari-
ance (R2=31.1%).
Being hypertensive, having a history of a myocardial 
infarction or ischaemic heart disease, having previously 
had a TIA, having active cancer, depression, rheumatoid 
arthritis or chronic obstructive pulmonary disease were 
not shown to be significantly associated with AHLOS. 
Furthermore, admissions to hospitals 6 and 8 were also 
not shown to be significantly associated with a difference 
in AHLOS compared with hospital 1 admissions.
Multiple linear regression
Multiple linear regression results for AHLOS are 
summarised in table 3 and shows that 42.7% of the varia-
tion in AHLOS has been explained. Sex, recurrent stroke, 
diabetes mellitus, hypercholesterolaemia, previous 
cancer, a prestroke mRS score of 1 to 3 (with reference 
to a score of 0) and living at home independently without 
formal care prior to stroke were no longer statistically 
associated with AHLOS in multiple regression (p>0.05). 
Furthermore, being admitted to hospital 3 or 4 as 
opposed to hospital 1 were no longer associated with a 
significant difference in AHLOS. No variables included 
from the univariable analysis with p>0.05 became statis-
tically significant in the multivariable analysis, except for 
living in an institution prior to stroke which was associ-
ated with a 19% reduced AHLOS compared with those 
living independently without formal care. Developing an 
inpatient complication and having a discharge mRS score 
Figure 1 Flow chart of patient participation inclusion and exclusion for study analysis. AHLOS, acute hospital length of stay; 
TIA, transient-ischaemic attack.
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between 2 and 5 were still strongly positively related to 
AHLOS. After adjusting for patient covariates, AHLOS 
was still shown to significantly differ between hospitals, 
with the shortest and longest AHLOS observed for hospi-
tals 5 and 2, respectively.
There were no obvious differences between the results 
using complete cases only (see tables S5–6 in the online 
supplementary file 2) and multiple imputation.
Graphical exploratory analysis
Mean baseline AHLOS of each hospital (estimated 
from the multiple regression model) was plotted against 
hospital stroke volume and clustered by hospital type in 
figure 2. It appears that hospitals (of either type) that 
have larger stroke volumes have a shorter AHLOS than 
those with smaller stroke volumes when patient covariates 
are taken into account. To note also, hospital 2 deviates 
largely from all the other hospitals with respect to the 
number of patients with stroke treated daily outside the 
stroke unit (see figure S1 in the online supplementary 
file 2).
No discernible patterns were seen for mean baseline 
hospital AHLOS and staffing levels, surgery facilities, 
number of non-stroke patients treated on the stroke unit, 
bed numbers and IMD score (see figures S2–15 in the 
online supplementary file 2).
sensitivity analyses results
Excluding hospital 2 in our first sensitivity analysis did not 
alter our results (see table S7 in the online supplemen-
tary file 2). For our second sensitivity analysis, although 
the results were similar, the amount of variance explained 
reduced from an R2 value of 42.7% to 40%. Furthermore, 
significant differences in AHLOS were shown between 
our reference hospital and hospitals 3 and 4, which was 
not shown in our main analysis (see table S8 in the online 
supplementary file 2).
DIsCussIOn
This multicentre cohort study has demonstrated that 
substantial heterogeneities exist in stroke hospital service 
and staff provision across three counties in the East of 
England. After adjusting for patient characteristics and 
Table 1 Sample characteristics of patients included in 
analysis (n=2233) and missing data
Patient characteristic
Median (IQR) 
or no. (%)
Missing 
data (%)
Age, years 79 (70 to 86) 2 (0.1)
Sex, female 1165 (52) 2 (0.1)
Recurrent stroke* 448 (20) 30 (1)
Diabetes mellitus* 370 (17) 30 (1)
Dementia* 207 (9) 30 (1)
Hypercholesterolaemia* 355 (16) 30 (1)
Hypertensive* 1483 (66) 30 (1)
Myocardial Infarction or 
ischaemic heart disease*
517 (23) 30 (1)
TIA* 340 (15) 30 (1)
Previous cancer* 195 (9) 30 (1)
Active cancer* 137 (6) 30 (1)
Depression* 137 (6) 30 (1)
Rheumatoid arthritis* 154 (7) 30 (1)
COPD* 116 (5) 30 (1)
Prestroke mRS score 442 (20)
  0 914 (41)
  1 335 (15)
  2 191 (9)
  3 184 (8)
  4 and 5 167 (7)
Prestroke residence 51 (2)
  Independent living with formal 
care
210 (9)
  Independent living without 
formal care
1752 (78)
  Institution 220 (10)
Ischaemic stroke 1864 (83) 96 (4)
Oxford Community Stroke 
Project Classification
260 (12)
  LACS 503 (23)
  PACS 784 (35)
  POCS 279 (12)
  TACS 407 (18)
No brain lateralisation 244 (12) 167 (8)
Inpatient complication* 655 (29) 0 (0)
Discharge mRS score 50 (2)
  0 260 (12) 329 (15)
  1 352 (16)
  2 212 (9)
  3 291 (13)
  4 238 (11)
  5 137 (6)
  6 414 (19)
Continued
Patient characteristic
Median (IQR) 
or no. (%)
Missing 
data (%)
Winter admission 1159 (52) 0 (0)
Weekend admission 614 (27) 0 (0)
*No information was assumed to indicate absence of 
condition or complication.
COPD, chronic obstructive pulmonary disorder; LACS, 
lacunar anterior circulation stroke; mRS, modified Rankin 
Scale; PACS, partial anterior circulation stroke; POCS, 
posterior circulation stroke; TACS, total anterior circulation 
stroke; TIA, transient ischaemic attack.
Table 1 Continued 
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confounding factors, we have shown that AHLOS signifi-
cantly differed between hospitals. This suggests that the 
heterogeneities we see in stroke care between hospitals 
have an effect on AHLOS of these patients. It also appears 
from our exploratory analysis that the volume of patients 
with stroke admitted to hospital may play a role in partially 
explaining these hospital-level AHLOS differences. 
Furthermore, the large deviation in AHLOS of hospital 2 
seems to be related to the number of patients with stroke 
that were not being treated in their stroke unit.
In agreement with our findings, two previous studies in 
Japan and Denmark have shown that hospitals with larger 
stroke volumes are those in which AHLOS is shorter.16 19 
The reason larger volume hospitals lead to more favour-
able outcomes may simply be down to the fact that ‘prac-
tice makes perfect’ that is, the stroke physicians in these 
hospitals treat a greater number of patients and hence 
are more experienced and able to deliver higher quality 
care.16 33 34 Svendsen et al, also demonstrated that patients 
with stroke admitted to large-volume stroke units have 
significantly greater odds of being treated and assessed 
earlier than those admitted to smaller-volume units, 
which could also explain their better outcomes.19
To translate these findings into practice may mean 
the centralisation of stroke services. Although this has 
been successfully implemented in urban centres such as 
Manchester and London,35 36 this may not be feasible in 
more rural areas where travel times would compromise 
timely thrombolysis treatment.10 37 Alternatively, a hub 
and spoke model of stroke care could be introduced 
whereby patients are first treated in their local hospital, 
and when stable for transfer are redirected to larger hub 
centres where they can gain access to more specialised 
care.38 Specifically, patients with severe stroke or with 
complex health needs could be redirected to these better 
performing larger-volume centres.
Any recommendations that would lead to changes in 
stroke volume for the benefit of a reduced AHLOS should 
not compromise the quality of care. However, it has previ-
ously been reported that larger stroke volumes are inde-
pendently associated with a lower risk of mortality.10 11 39 40 
Therefore, modifying this hospital factor may not only 
lead to a potential modest decrease in inpatient costs and 
more available bed days but could also be beneficial to 
the health outcomes of patients.
Table 2 Hospital characteristics per individual hospital self-reported by clinical leads or service managers at each hospital
Hospital characteristics 1 2 3 4 5 6 7 8
General characteristics
  Catchment population 400 000 160 000 350 000 230 000 680 000 300 000 240 000 275 000
  Hospital type Tertiary Secondary Secondary Secondary Tertiary Secondary Secondary Secondary
  Hospital stroke volume (no. of ASCNES 
admissions per month)
52 13 46 19 88 57 35 31
Facilities and services
  No. of hospital beds 1000 304 800 500 1237 611 488 460
  No. of stroke unit beds (per 100 admissions) 71 77 54 138 41 55 83 65
  No. of hospital beds per CT scanners 500 304 400 250 518 306 244 230
  Distance to vascular surgery (miles) 0 18 0 25 0 0 43 30
  Distance to neurosurgery (miles) 0 18 58 89 61 38 48 30
  Rehabilitation provision Onsite Onsite Offsite Offsite Offsite Onsite Offsite Onsite
  Early supported discharge provision No Yes No Yes Yes Yes No No
Stroke unit staffing levels*
  Senior doctors† 0.34 0.25 0.49 0.47 0.42 0.31 0.62 0.87
  Junior doctors† 0.55 0.65 0.72 0.59 0.56 0.64 0.12 0.25
  Healthcare associates and nurses (band 5–7) 9.2 8 6 7.4 7 5.3 6.5 10
  Physiotherapists (band 2–8) 0.55 1 0.79 0.4 0.91 0.78 0.69 1
  Occupational therapists (band 3–8) 0.49 0.5 1.4 0.59 0.6 0.58 0.52 1.1
  Speech and language therapists 0.39 0.15 0.2 0.18 0.35 0.03 0.26 0.1
No. of non-stroke patients treated daily on stroke 
unit (per five stroke unit beds)
0.27 0 0.10 0.47 0.05 0.31 0.17 0
No. of patients with stroke treated daily outside 
stroke unit (per five stroke unit beds)
0.14 5 0 0.30 0.01 0.41 0 0
Median AHLOS (IQR) 8 (4 to 20) 29 (24 to 42) 11 (5 to 27) 14 (4 to 30) 8 (4 to 14) 10 (5 to 22) 11 (6 to 23) 7 (3 to 20)
*Number of fte staff per five stroke unit beds (weighted average for the four study periods taken). NHS banding refers to the pay scale system of healthcare staff 
in the UK and relates to their level of experience. Higher bands reflect higher pay and experience.
†Weekday numbers only.
AHLOS, acute hospital length of stay; ASCNES, Anglia Stroke Clinical Network Evaluation Study.
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The large variation in AHLOS between hospital 2 and 
the other hospitals in our study is also interesting to note. 
This coincides with a stark contrast in the number of 
patients with stroke that were not treated in a stroke unit 
in hospital 2 compared with the others. It could there-
fore be surmised that the large deviation in AHLOS of 
this hospital is driven by a lack of access to stroke unit 
care. This would be unsurprising given that stroke unit 
care has been consistently found to improve outcomes, 
including AHLOS, possibly due to a greater intensity of 
physiological monitoring, therapy and early mobilisation 
implemented in these discrete units.41–44
Other hospital-level factors that have been shown to 
influence a stroke patient’s AHLOS include hospital size 
and teaching status.12 16–18 However, these relationships 
were not apparent in our exploratory analysis. To inves-
tigate these and other hospital characteristics further, 
we require a larger sample of hospitals. This issue with 
sample size is also apparent when we study hospital 8 
which, although has one of the lowest AHLOS, also has 
one of the smallest volumes of stroke patients in the 
study, and therefore contradicts our previous finding. 
Such a discrepancy is likely a reflection of the small 
number of hospitals assessed, as there are likely to be 
several competing factors playing a role in determining 
hospital-level AHLOS variance. For example, although 
hospital 8 has one of the lowest stroke volumes, it has the 
highest number of fte senior doctors, healthcare associ-
ates and nurses and physiotherapists per five beds, and 
the lowest number of hospital beds per CT scanners out 
of all the hospitals studied. Staffing levels may be what 
is responsible for this supposed contradiction as they 
are likely to be an important determinant of AHLOS, 
given that higher nurse: bed ratios have been shown to 
be important in reducing other stroke-related outcomes, 
such as mortality.7 10
Although not the focus of our study, we have also 
demonstrated several important patient variables that 
influence AHLOS, specifically discharge mRS, having 
dementia or having an inpatient complication. Other 
researchers have confirmed the strength of these 
Table 3 Multiple regression analysis for AHLOS (n=2233; 
R2=42.7%)
Patient characteristic eβ* 95% CI* Ρ value
Age, years 1.01 1.00 to 1.01 <0.001
Sex, female 1.01 0.94 to 1.09 0.79
Recurrent stroke 1.03 0.94 to 1.12 0.57
Diabetes mellitus 1.06 0.97 to 1.17 0.21
Dementia 1.28 1.12 to 1.46 <0.001
Hypercholesterolaemia 0.94 0.85 to 1.05 0.27
Myocardial infarction or 
ischaemic heart disease*
1.00 0.92 to 1.09 0.98
Previous cancer 1.12 0.99 to 1.27 0.08
COPD 0.90 0.77 to 1.06 0.21
Prestroke mRS score 
(reference 0)
<0.001
  1 1.06 0.95 to 1.19 0.28
  2 0.90 0.77 to 1.04 0.15
  3 0.94 0.80 to 1.11 0.47
  4 and 5 0.71 0.59 to 0.86 <0.001
Prestroke residence 
(reference independent living 
without formal care)
<0.001
  Independent living with 
formal care
1.07 0.94 to 1.23 0.92
  Institution 0.81 0.69 to 0.95 0.01
Haemorrhagic stroke 0.80 0.71 to 0.90 <0.001
Oxford Community Stroke 
Project Classification 
(reference LACS)
<0.001
  PACS 1.30 1.18 to 1.42 <0.001
  POCS 1.34 1.18 to 1.53 <0.001
  TACS 1.29 1.13 to 1.48 <0.001
No brain lateralisation 0.85 0.75 to 0.96 0.01
Inpatient complication 1.70 1.56 to 1.85 <0.001
Discharge mRS score 
(reference 0)
<0.001
  1 1.15 1.01 to 1.31 0.04
  2 1.74 1.50 to 2.04 <0.001
  3 2.70 2.32 to 3.13 <0.001
  4 3.51 2.98 to 4.14 <0.001
  5 5.07 4.19 to 6.14 <0.001
  6 1.24 1.05 to 1.48 0.01
Winter admission 1.15 1.08 to 1.24 <0.001
Weekend admission 1.03 0.95 to 1.11 0.50
Hospital (reference 1) <0.001
  2 2.09 1.38 to 3.17 0.001
  3 1.07 0.94 to 1.22 0.29
  4 1.08 0.90 to 1.31 0.40
  5 0.78 0.69 to 0.87 <0.001
Continued
Patient characteristic eβ* 95% CI* Ρ value
  6 0.93 0.81 to 1.07 0.33
  7 1.15 1.00 to 1.32 0.05
  8 0.82 0.70 to 0.94 0.01
*β estimates and 95% CIs were calculated for predicted 
log AHLOS. Prior to reporting they were transformed back 
to AHLOS through exponentiation and represent geometric 
mean AHLOS.
AHLOS, acute hospital length of stay; COPD, chronic 
obstructive pulmonary disorder; LACS, lacunar anterior 
circulation stroke; mRS, modified Rankin Scale; PACS, 
partial anterior circulation stroke; POCS, posterior 
circulation stroke; TACS, total anterior circulation stroke.
Table 3 Continued 
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relationships. For example, Fujinio et al, showed that 
mRS before discharge was associated with a difference 
in 5.77 days in AHLOS,16 while another study showed 
that dementia increased AHLOS by 6.5 days.14 Compli-
cations such as congestive heart failure, falls, UTI and 
pneumonia have also been shown to prolong a patient’s 
AHLOS.15 45 46 It is therefore important for any future 
studies exploring hospital-level factors to properly adjust 
for these patient variables, in addition to National Insti-
tute for Health Stroke Scale (NIHSS) which is another 
important covariate. This is especially pertinent given that 
the studies examining hospital-level factors and AHLOS 
in stroke to date have failed to adjust for these specifically. 
Finally, our findings in relation to other patient factors 
such as age, sex, stroke type and prestroke residence are 
in general agreement with other literature.12–14 47 48
The main strength of our study is its prospective design 
and the detailed patient-level data we obtained. This 
allowed us to gain a better understanding of the extent 
to which the variation in AHLOS exists over and above 
patient characteristics. We have optimised the use of avail-
able NHS data as the starting block for informing future 
pragmatic real-world setting randomised controlled trials 
by first identifying potential health service factors that 
could lead to important interventions. Furthermore, the 
findings of this study can presently be used to inform clini-
cians, healthcare service providers, commissioners and 
policy makers as to where improvements can be achieved 
in stroke care. The robust statistical analysis has allowed 
easy and quick visualisation of notable patterns in the 
dataset and provides a candid assessment of the research 
objectives by considering the limits of inference due to 
the small number of hospitals. Multiple imputation has 
also reduced potential bias that may have otherwise been 
introduced from complete case analysis alone.
The major limitation of this study was the small number 
of hospitals that has restricted the conclusions we can 
make from our exploratory analysis of hospital charac-
teristics. Furthermore, although NIHSS and a patient’s 
discharge destination has been shown to be associated 
with stroke patients’ AHLOS,14 20 they were excluded 
as covariates from the main analysis. As NIHSS scores 
were only calculated for those who were potentially 
eligible for thrombolysis at the time of our study, the 
incompleteness was not missing at random and would 
have introduced information bias into our results. As 
discharge mRS and discharge destination both included 
a categorical factor representing inpatient death only 
one of these variables could be included into the analysis 
due to issues of multicollinearity. However, we hypoth-
esised that discharge mRS score could more readily 
explain a patient’s AHLOS while also serving as a proxy 
for discharge destination. In addition, socioeconomic 
status which has also been shown to relate to AHLOS in 
patients with stroke,18 and differences in palliative care 
policies were not known. This means that any remaining 
difference in AHLOS between hospitals may be due 
to hospital-level factors as well as other unmeasured 
confounders. We also did not collect data on patient 
ethnicity although this has previously been associated 
with AHLOS.49–51While we cannot provide exact ethnic 
mix, the region where the study was conducted serves 
mainly a white British Caucasian population, with other 
races making up a very small minority.52
A further limitation of this study is that the hospital 
characteristics were self-reported by clinical leads or 
service managers at each hospital. This may have intro-
duced information bias, especially with regard to the 
reported fte staffing levels, and the number of patients 
treated within or outside the stroke unit.
Furthermore, as this study covers eight NHS hospitals 
in the East of England that span both urban and rural 
regions, and as NHS policies are fairly standard, we 
believe these sites are generally representative of others 
across the UK. However, as we lacked an adequate number 
of hospitals to run a multilevel model with hospital as a 
random effect, our findings cannot be generalised to 
other healthcare settings outside the UK with differing 
national policies.
In summary, the heterogeneities that exist in stroke 
care at the regional UK level have the ability to lead to 
differences in stroke patient outcomes such as AHLOS. 
This provides a powerful message for patients, clini-
cians, service providers and policymakers—that there 
are modifiable hospital factors that may determine 
better outcomes in stroke. For example, a hub and spoke 
model of care could be advocated to increase efficiencies 
while also providing for more beneficial stroke health 
outcomes. Countries that are in the process of developing 
their healthcare systems can use these findings to inform 
their decision making in delivering optimal care.
Figure 2 Model estimates of mean baseline acute hospital 
length of stay (AHLOS) per hospital (in days) against hospital 
stroke volume and clustered by hospital type with 95% CIs. 
Multiple regression model was adjusted for patient covariates 
that had a p value <0.3 in univariable analysis.
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